Turkey ready to purchase a second batch of Russia S-400 air defense missile systems


According to information published by the Daily Sabah website on August 29, 2021, Turkey will purchase a second batch of Russian-made S-400 air defense missile systems. Turkey is very close to signing a new contract with the Russian defense industry.
Follow Army Recognition on Google News at this link


Army Recognition Global Defense and Security news
TEL Transporter Erector Launcher unit of Russian-made S-400 air defense missile system. (Picture source Vitaly Kuzmin)


According to information provided by Alexander Mikheev, the head of Russia’s state arms exporter Rosoboronexport,, Russia is in the process to sign a new with Turkey for the delivery of more S-400 air defense missile systems.

The first reports about the talks between Russia and Turkey on the deliveries of S-400 air defense missile systems emerged in November 2016. Russia confirmed in September 2017 that the $2.5 bln contract had been signed. Under the deal, Ankara will get a regimental set of S-400 air defense missile systems (two battalions).

In September 2017, Russia said that it had signed a contract worth 2.5 billion dollars with Turkey for the delivery of S-400 systems. The deal envisages partial technology transfer to the Turkish side. In November 2019, Russia has delivered the first batch of S-400 air defense missile systems to Turkey.

The S-400 also nicknamed Trium, NATO code-named SA-21 Growler is an air defense missile system developed in the 1990s by Russia's Almaz Central Design Bureau. It enters into service with the Russian army in 2007.

A battery of S-400 includes a multifunction radar, autonomous detection and targeting systems, anti-aircraft missile systems, launchers, and command and control center. The missile of the S-400 is able to destroy a wide range of aerial targets including aircraft, unmanned aerial vehicles (UAVs), ballistic and cruise missile with a maximum range of 400 km and an altitude of up to 30 km. It can simultaneously engage 36 targets.